Skip to Content
You are currently on the new version of our website. Access the old version .
MoleculesMolecules
  • Article
  • Open Access

27 June 2018

13 Pages

Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors

,
,
,
,
,
,
and
1
School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang 330013, Jiangxi, China
2
School of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, Jiangxi, China
3
School of Chemistry and Bioengineering, Yichun University, Yichun 336000, Jiangxi, China
*
Authors to whom correspondence should be addressed.
This article belongs to the Section Medicinal Chemistry

Abstract

Five series of novel phenylsulfonylurea derivatives, 19a–d, 20a–d, 21a–d, 22a–d and 23a–d, bearing 4-phenylaminoquinoline scaffold were designed, synthesized and their IC50 values against four cancer cell lines (HepG-2, A549, PC-3 and MCF-7) were evaluated. Most compounds showed moderate cytotoxicity activity against the cancer cell lines. Structure–activity relationships (SARs) and pharmacological results indicated that introduction of 4-aminoquinoline scaffold and phenylsulfonylurea scaffold were beneficial for anti-tumor activity. Moreover, para-methoxyl substitution of 4-anilino moiety and para-halogen substitution of phenylsulfonylurea have different impacts on different series of compounds. Furthermore, the micromolecule group substitution in the 6-position of the quinoline ring have a slight impact on the cellular activity of the target compounds.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.